XML 22 R10.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Earnings Per Share | 9 Months Ended
--- | ---
Jan. 25, 2025
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share We follow the provisions of Accounting Standards Codification 260, Earnings Per Share ("ASC 260"), where basic earnings per share ("EPS") is computed by dividing income attributable to common shareholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution which may occur if securities or other obligations to issue common stock were exercised or converted into shares of common stock or resulted in the issuance of shares of common stock which share in our earnings. The following is a reconciliation of the net income and common share amounts used in the calculation of basic and diluted EPS for the three and nine months ended January 25, 2025 and January 27, 2024:
| Three Months Ended |  | Nine Months Ended
| January 25, 2025 |  | January 27, 2024 |  | January 25, 2025 |  | January 27, 2024
Earnings per share - basic |  |  |  |  |  |  |
Net (loss) income | $ | (17,156) |  |  | $ | 10,742 |  |  | $ | (696) |  |  | $ | 32,103 |
Weighted average shares outstanding | 47,764 |  |  | 46,173 |  |  | 46,944 |  |  | 45,975 |
Basic earnings per share | $ | (0.36) |  |  | $ | 0.23 |  |  | $ | (0.01) |  |  | $ | 0.70 |
Earnings per share - diluted |  |  |  |  |  |  |
Net (loss) income | $ | (17,156) |  |  | $ | 10,742 |  |  | $ | (696) |  |  | $ | 32,103 |
Change in fair value of convertible note | — |  |  | (6,340) |  |  | — |  |  | — |
Interest expense on convertible note, net of tax | — |  |  | 404 |  |  | — |  |  | — |
Diluted net income | $ | (17,156) |  |  | $ | 4,806 |  |  | $ | (696) |  |  | $ | 32,103 |
Weighted average common shares outstanding | 47,764 |  |  | 46,173 |  |  | 46,944 |  |  | 45,975 |
Dilution associated with stock compensation plans | — |  |  | 627 |  |  | — |  |  | 633 |
Dilution associated with convertible note | — |  |  | 4,037 |  |  | — |  |  | — |
Weighted average common shares outstanding, assuming dilution | 47,764 |  |  | 50,837 |  |  | 46,944 |  |  | 46,608 |
Diluted earnings per share | $ | (0.36) |  |  | $ | 0.09 |  |  | $ | (0.01) |  |  | $ | 0.69 |
During the three months ended January 25, 2025, a total of 934 shares of potential common stock related to stock compensation plans were excluded from the computation of diluted EPS because the effects would be anti-dilutive. The excluded shares include options outstanding to purchase 29 shares of common stock with a weighted average exercise price of $11.87. For the three months ended January 27, 2024, options outstanding to purchase 484 shares of common stock with a weighted average exercise price of $10.73 were not included in the computation of diluted EPS because the effects would be anti-dilutive. During the nine months ended January 25, 2025, a total of 992 shares of potential common stock relating to the stock compensation plan were excluded from the computation of diluted EPS because the effects would be anti-dilutive. The excluded shares include options outstanding to purchase 51 shares of common stock with a weighted average exercise price of $10.43. For the nine months ended January 27, 2024, options outstanding to purchase 695 shares of common stock with a weighted average exercise price of $10.30 were not included in the computation of diluted EPS because the effects would be anti-dilutive. During the three months ended January 25, 2025, 3,079 potential shares of common stock issuable upon conversion of the senior secured convertible note dated May 11, 2023 issued to Alta Fox Opportunities Fund, LP (the Holder," and collectively with its affiliates, "Alta Fox") during fiscal 2024 (the "Convertible Note") were not included in the computation of diluted EPS, as the effect would be anti-dilutive. The 2,218 common shares attributed to settling a portion of the Convertible Note, but not yet been issued, were weighted for the number of days outstanding from the settlement date and included in the weighted average shares outstanding in the computation of diluted EPS. For the nine months ended January 25, 2025, 3,697 potential common shares issuable upon conversion of the Convertible Note were not included in the computation of diluted EPS, as the effect would be anti-dilutive. The 2,218 common shares attributed to settling a portion of the Convertible Note, but not yet been issued, were weighted for the number of days outstanding from the settlement date and included in the weighted average shares outstanding in the computation of diluted EPS. During the nine months ended January 27, 2024, 3,875 potential shares of common stock issuable upon conversion of the Convertible Note were not included in the computation of diluted EPS, as the effect would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration